Funding for this research was provided by:
Fogarty International Center (TW010452-01)
Teva Pharmaceutical Industries
Received: 23 August 2019
Accepted: 16 March 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: The study design, consent forms, and data collection tools were approved by the Program for the Protection of Human Subjects at the Icahn School of Medicine at Mount Sinai; the Institutional Review Board of the Navrongo Health Research Centre; and the Human Research Protection Office at Columbia University. All NPHWs completed written informed consent forms prior to participating in the study. This included consent to publish participants’ anonymous quotes.
: No consent was requested, or given, for any other identifiers such as images, video, or other personal details, as we deemed these data not applicable to this study.
: The authors declare that they have no competing interests.